Sofinnova Ventures »

Vaxcyte shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 51k 58.11

More positions owned by Sofinnova Ventures

Natera (NTRA)
iShares TR Russell 2000 Etf Put Option (IWM)
United Therapeutics Corporation Put Option (UTHR)
SPDR Series Trust State Street Spd Put Option (XBI)
Bristol Myers Squibb (BMY)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Vera Therapeutics Cl A (VERA)
AstraZeneca Ord (AZN)
Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Cogent Biosciences (COGT)
iShares TR Ishares Biotech Put Option (IBB)
Celcuity (CELC)
Ultragenyx Pharmaceutical (RARE)
Axsome Therapeutics Put Option (AXSM)
Rapport Therapeutics (RAPP)

View all positions for Sofinnova Ventures

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
State Street Corporation
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Geode Capital Management
Kynam Capital Management

View all funds holding Vaxcyte